RITUXIMAB-ABBS vs RIVASTIGMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RITUXIMAB-ABBS vs RIVASTIGMINE: Safety Overview
| Metric | RITUXIMAB-ABBS | RIVASTIGMINE |
|---|---|---|
| Total FAERS Reports | 4,347 | 9,123 |
| Deaths Reported | 432 | 2,232 |
| Death Rate | 9.9% | 24.5% |
| Hospitalizations | 1,087 | 2,716 |
| Average Patient Age | 53.5 yrs | 80.0 yrs |
| % Female Patients | 74.2% | 59.5% |
| FDA Approval Date | N/A | Apr 21, 2000 |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | TRANSDERMAL |
| Marketing Status | Prescription | Discontinued |